The blockbuster drug Avastin should no longer be used in advanced breast cancer patients because there's no proof that it extends their lives and it presents dangerous side effects, the government declared Friday.
The Institute of Medicine reports that sexual orientation and gender identity should be addressed by researchers, much as race and identity are routinely questioned.